SABAH HADI: Open Payments
NPI 1396818803 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 23 payments from 9 companies in 2025. Trend: 2023 $1,092 · 2024 $2,211 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 9 | $277 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $95 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Boston Scientific Corporation | 1 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $30 |
| Corium, LLC | 1 | $26 |
Products named: REXULTI, COBENFY, TRINTELLIX, Auvelity, CAPLYTA, Qelbree, OBSIDIO, Jornay PM.
Industry payments across MD — which companies pay providers there.
